Cognitive Effects of Psychiatric Medications in Personal Injury Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 9 min read

Psychiatric medications prescribed after a traumatic injury can produce cognitive side effects -- including sedation, impaired concentration, memory difficulties, and slowed processing speed -- that compound the functional impairment caused by the injury itself. Understanding these cognitive effects is critical for both patient management and case documentation.

Psychiatric medications prescribed after a traumatic injury can produce cognitive side effects that compound the functional impairment caused by the injury itself. Sedation, impaired concentration, memory difficulties, and slowed processing speed are common side effects of medications that PI patients depend on for PTSD, anxiety, depression, and insomnia management. Understanding these cognitive effects is critical for patient safety, treatment optimization, and accurate case documentation.

• Many psychiatric medications cause dose-dependent cognitive side effects including sedation, memory impairment, and reduced processing speed
• Cognitive effects from medications compound the cognitive impairment caused by the underlying injury (especially TBI)
• Treatment optimization balances psychiatric symptom control against cognitive side effect burden
• Medication-related cognitive impairment is a legitimate component of functional limitation in PI cases
• LienScripts pharmacist oversight helps identify and manage cognitive side effects across the medication regimen

How Psychiatric Medications Affect Cognition

Sedation and Alertness

Sedation is the most common cognitive effect of psychiatric medications in PI patients. Trazodone, hydroxyzine, doxepin, quetiapine, and first-generation antihistamines all produce dose-dependent sedation that can impair daytime functioning. For patients who also take opioid analgesics and muscle relaxants, the cumulative sedation burden can significantly affect the ability to work, drive, and perform daily activities.

Memory and Learning

Benzodiazepines (lorazepam, alprazolam, clonazepam) are well-documented to impair anterograde memory -- the ability to form new memories. This effect occurs at therapeutic doses and can persist for hours after dosing. For PI patients already experiencing memory difficulties from TBI or PTSD-related concentration problems, benzodiazepine-induced memory impairment adds another layer of cognitive dysfunction.

Processing Speed

Multiple psychotropic medication classes can slow cognitive processing speed. Anticonvulsants used for mood stabilization or neuropathic pain (topiramate, valproate, gabapentin) are particularly associated with slowed processing and "mental fog." These effects are dose-dependent and may be managed through dose optimization.

Attention and Concentration

SSRI initiation can temporarily worsen concentration during the first 2-4 weeks of treatment before improving it as the underlying depression or anxiety responds. SNRIs, particularly at higher doses, may produce jitteriness or agitation that impairs sustained attention. Understanding these time-dependent effects helps clinicians set appropriate expectations.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist with clinical experience in psychiatric pharmacy, explains: "Cognitive side effects from psychiatric medications are not simply inconveniences -- they are functional impairments that directly affect the patient's ability to work, drive, attend appointments, and participate in daily life. In a PI case, these medication-related cognitive effects are a legitimate component of the damages caused by the accident, because the medications would not be necessary but for the injury."

Medications With Significant Cognitive Effects

High Cognitive Impact

• Benzodiazepines (lorazepam, alprazolam): Memory impairment, sedation, psychomotor slowing
• Topiramate: "Topiramate cognitive syndrome" -- word-finding difficulty, reduced processing speed
• Quetiapine (especially at higher doses): Sedation, cognitive dulling
• First-generation antihistamines (diphenhydramine, hydroxyzine at high doses): Anticholinergic cognitive impairment

Moderate Cognitive Impact

• Trazodone: Morning sedation ("hangover effect") at higher doses
• Gabapentin/pregabalin: Sedation, dizziness, concentration difficulty
• Mirtazapine: Sedation (most prominent at lower doses due to histamine predominance)
• Valproate: Cognitive slowing, tremor

Lower Cognitive Impact

• SSRIs (sertraline, escitalopram): Minimal cognitive impairment; may improve cognition by treating the underlying condition
• Buspirone: No clinically significant cognitive effects
• Prazosin: Minimal cognitive effects (primarily orthostatic hypotension risk)
• Ramelteon: No next-day cognitive impairment

Managing Cognitive Side Effects in PI Patients

Medication Timing

Moving sedating medications to bedtime (trazodone, quetiapine, hydroxyzine) reduces daytime cognitive impact while maintaining therapeutic benefit during sleep.

Dose Optimization

Using the minimum effective dose reduces cognitive side effects without sacrificing symptom control. This is particularly important for topiramate, gabapentin, and benzodiazepines.

Agent Selection

Choosing agents with lower cognitive impact (buspirone over benzodiazepines for anxiety, ramelteon over zolpidem for insomnia) minimizes cognitive burden while maintaining treatment efficacy.

Regimen Simplification

Reducing the total number of sedating agents when clinically possible -- for example, using duloxetine (which treats both pain and depression) instead of separate SSRI and gabapentin -- reduces cumulative cognitive side effects.

Documentation Value

Medication-related cognitive impairment is a legitimate component of functional limitation in PI cases. The LienScripts MERIT (Medication Evaluation & Rationale for Injury Treatment) report documents all medications the patient takes, enabling attorneys to identify the cumulative cognitive burden and include medication side effects in the functional impairment narrative of the demand package.

Related Resources

• Polypharmacy in Psychiatric Medications After an Accident
• Drug Interaction Guide for Personal Injury
• Concussion and TBI Medication Guide